The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.
Full Title of Study: “Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?”
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: October 1, 2018
- Procedure: hepatectomy
- Hepatectomy for patients with recurrent intrahepatic cholanigocarcinoma
Clinical Trial Outcome Measures
- Time Frame: 1977~2014
- Including overall survival and disease free survival
Participating in This Clinical Trial
- R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.
- (1)Patient with R1 or R2 resection
- (2)Distant metastasis noted when laparotomy
- (3)Surgical mortality
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Chang Gung Memorial Hospital
- Provider of Information About this Clinical Study
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.